806 related articles for article (PubMed ID: 27227483)
21. MHC class I and TCR avidity control the CD8 T cell response to IL-15/IL-15Rα complex.
Stoklasek TA; Colpitts SL; Smilowitz HM; Lefrançois L
J Immunol; 2010 Dec; 185(11):6857-65. PubMed ID: 21041729
[TBL] [Abstract][Full Text] [Related]
22. Selective responsiveness to common gamma chain cytokines in peripheral blood-derived cytotoxic T lymphocytes induced by Melan-A/MART-1(27-35)targeted active specific immunotherapy.
von Holzen U; Adamina M; Bolli M; Weber WP; Zajac P; Groeper C; Reschner A; Feder C; Schumacher R; Marti W; Oertli D; Heberer M; Spagnoli GC
Int J Cancer; 2005 Jun; 115(2):248-55. PubMed ID: 15688403
[TBL] [Abstract][Full Text] [Related]
23. Interleukin-15 in cancer immunotherapy: IL-15 receptor complex versus soluble IL-15 in a cancer cell-delivered murine leukemia model.
Berger A; Colpitts SJ; Seabrook MSS; Furlonger CL; Bendix MB; Moreau JM; McKillop WM; Medin JA; Paige CJ
J Immunother Cancer; 2019 Dec; 7(1):355. PubMed ID: 31856922
[TBL] [Abstract][Full Text] [Related]
24. Artificial antigen-presenting cells transduced with telomerase efficiently expand epitope-specific, human leukocyte antigen-restricted cytotoxic T cells.
Dupont J; Latouche JB; Ma C; Sadelain M
Cancer Res; 2005 Jun; 65(12):5417-27. PubMed ID: 15958591
[TBL] [Abstract][Full Text] [Related]
25. Tumor eradication by hepatitis B virus X antigen-specific CD8+ T cells in xenografted nude mice.
Chun E; Lee J; Cheong HS; Lee KY
J Immunol; 2003 Feb; 170(3):1183-90. PubMed ID: 12538674
[TBL] [Abstract][Full Text] [Related]
26. Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes.
Tan LC; Mowat AG; Fazou C; Rostron T; Roskell H; Dunbar PR; Tournay C; Romagné F; Peyrat MA; Houssaint E; Bonneville M; Rickinson AB; McMichael AJ; Callan MF
Arthritis Res; 2000; 2(2):154-64. PubMed ID: 11062606
[TBL] [Abstract][Full Text] [Related]
27. The Sushi domain of soluble IL-15 receptor alpha is essential for binding IL-15 and inhibiting inflammatory and allogenic responses in vitro and in vivo.
Wei Xq ; Orchardson M; Gracie JA; Leung BP; Gao Bm ; Guan H; Niedbala W; Paterson GK; McInnes IB; Liew FY
J Immunol; 2001 Jul; 167(1):277-82. PubMed ID: 11418660
[TBL] [Abstract][Full Text] [Related]
28. IL-15 can signal via IL-15Rα, JNK, and NF-κB to drive RANTES production by myeloid cells.
Chenoweth MJ; Mian MF; Barra NG; Alain T; Sonenberg N; Bramson J; Lichty BD; Richards CD; Ma A; Ashkar AA
J Immunol; 2012 May; 188(9):4149-57. PubMed ID: 22447977
[TBL] [Abstract][Full Text] [Related]
29. Transregulation of memory CD8 T-cell proliferation by IL-15Ralpha+ bone marrow-derived cells.
Schluns KS; Klonowski KD; Lefrançois L
Blood; 2004 Feb; 103(3):988-94. PubMed ID: 14512307
[TBL] [Abstract][Full Text] [Related]
30. Long-lived antitumor CD8+ lymphocytes for adoptive therapy generated using an artificial antigen-presenting cell.
Butler MO; Lee JS; Ansén S; Neuberg D; Hodi FS; Murray AP; Drury L; Berezovskaya A; Mulligan RC; Nadler LM; Hirano N
Clin Cancer Res; 2007 Mar; 13(6):1857-67. PubMed ID: 17363542
[TBL] [Abstract][Full Text] [Related]
31. IL-15 Trans-Signaling with the Superagonist RLI Promotes Effector/Memory CD8+ T Cell Responses and Enhances Antitumor Activity of PD-1 Antagonists.
Desbois M; Le Vu P; Coutzac C; Marcheteau E; Béal C; Terme M; Gey A; Morisseau S; Teppaz G; Boselli L; Jacques Y; Béchard D; Tartour E; Cassard L; Chaput N
J Immunol; 2016 Jul; 197(1):168-78. PubMed ID: 27217584
[TBL] [Abstract][Full Text] [Related]
32. In vivo antitumor function of tumor antigen-specific CTLs generated in the presence of OX40 co-stimulation in vitro.
Pham Minh N; Murata S; Kitamura N; Ueki T; Kojima M; Miyake T; Takebayashi K; Kodama H; Mekata E; Tani M
Int J Cancer; 2018 Jun; 142(11):2335-2343. PubMed ID: 29313971
[TBL] [Abstract][Full Text] [Related]
33. Modeling the CD8+ T effector to memory transition in adoptive T-cell antitumor immunotherapy.
Rolle CE; Carrio R; Malek TR
Cancer Res; 2008 Apr; 68(8):2984-92. PubMed ID: 18413768
[TBL] [Abstract][Full Text] [Related]
34. Cord blood-derived T cells allow the generation of a more naïve tumor-reactive cytotoxic T-cell phenotype.
Kwoczek J; Riese SB; Tischer S; Bak S; Lahrberg J; Oelke M; Maul H; Blasczyk R; Sauer M; Eiz-Vesper B
Transfusion; 2018 Jan; 58(1):88-99. PubMed ID: 29023759
[TBL] [Abstract][Full Text] [Related]
35. Homeostatic proliferation but not the generation of virus specific memory CD8 T cells is impaired in the absence of IL-15 or IL-15Ralpha.
Wherry EJ; Becker TC; Boone D; Kaja MK; Ma A; Ahmed R
Adv Exp Med Biol; 2002; 512():165-75. PubMed ID: 12405201
[TBL] [Abstract][Full Text] [Related]
36. Stimulation of cells from a non-invaded and an invaded lymph node with a HER-2+ tumor with peptides corresponding to T-cell epitopes E75 and G89 induced expansion of central memory cells (TCM) from the metastasis-negative lymph nodes.
Ko BK; Efferson CL; Kawano K; Kuerer HM; Sahin A; Murray JL; Ioannides CG
Int J Oncol; 2004 Jun; 24(6):1413-8. PubMed ID: 15138582
[TBL] [Abstract][Full Text] [Related]
37. No requirement of trans presentations of IL-15 for human CD8 T cell proliferation.
Ota N; Takase M; Uchiyama H; Olsen SK; Kanagawa O
J Immunol; 2010 Nov; 185(10):6041-8. PubMed ID: 20926799
[TBL] [Abstract][Full Text] [Related]
38. Dissociation of its opposing immunologic effects is critical for the optimization of antitumor CD8+ T-cell responses induced by interleukin 21.
Ansén S; Butler MO; Berezovskaya A; Murray AP; Stevenson K; Nadler LM; Hirano N
Clin Cancer Res; 2008 Oct; 14(19):6125-36. PubMed ID: 18829491
[TBL] [Abstract][Full Text] [Related]
39. IL-15R alpha-IgG1-Fc enhances IL-2 and IL-15 anti-tumor action through NK and CD8+ T cells proliferation and activation.
Wu Z; Xu Y
J Mol Cell Biol; 2010 Aug; 2(4):217-22. PubMed ID: 20671116
[TBL] [Abstract][Full Text] [Related]
40. Soluble recombinant CMVpp65 spanning multiple HLA alleles for reconstitution of antiviral CD4+ and CD8+ T-cell responses after allogeneic stem cell transplantation.
Paine A; Oelke M; Tischer S; Heuft HG; Blasczyk R; Eiz-Vesper B
J Immunother; 2010 Jan; 33(1):60-72. PubMed ID: 19952955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]